Providers utilize business intelligence to monitor referral patterns and collaborate with clinicians who order their services. Such analytics tools have also been deployed in the specialty to improve productivity, track patient satisfaction and bolster quality.
Four of five hospital leaders trust the accuracy of their institution’s data. Yet almost half of useable data gets underutilized if not completely untapped for guiding business and clinical decisions.
Hospital employment models, reimbursement policies and private equity have all led to a massive reduction in the number of cardiologists working for a private practice, ACC President Cathie Biga, MSN, told Cardiovascular Business.
Alison Bailey, MD, co-chair of the business of cardiology sessions at ACC.24, emphasized that reimbursement cuts can have a long-term negative impact on patient.
All around the world, people are increasingly wise to the advance of AI. More than a few are growing ever more uneasy about it. And yet workers equipped with AI are both more productive and better at their jobs.
The largest hospital system in a large Western state is feeling the heat of negative publicity over how it goes after patients who owe the system money.
Among the 20 million-plus Americans who have unpaid medical bills totaling more than $250, almost a quarter—5 million people—owe between $2,001 and $5,000.
As AI continues infiltrating healthcare at nearly every level, the technology’s potential for good and ill must become—or remain—a preeminent concern for hospital boards of trustees.
It’s not easy to get patients, providers, payers, vendors and regulators to agree on any one aspect of healthcare delivery. But the CDRH recently managed to get everyone to settle on a working definition of transparency.
Members of C-suites around the world are making room for a new teammate: the CAIO. In healthcare, some organizations are hiring for the even more specialized position of CHAIO, for chief health AI officer.
Jeffrey Kuvin, MD, one of the leading voices behind efforts to create a new Board of Cardiovascular Medicine, spoke with Cardiovascular Business about where things stand today.
Half a year after President Biden officially directed federal agencies in the executive branch’s bailiwick to “seize the promise and manage the risks” of AI, the White House has posted a status report.
U.S. physicians often receive payments from medical device manufacturers and pharmaceutical companies. New research in JAMA found a connection between receiving such payments and using specific devices—should the industry be concerned?